GeoVax moves higher before the bell as traders watch for Mpox vaccine news
• GeoVax shares rallied in pre-market after closing Friday at $1.23.• The move follows last week’s Q1 update, with no new results from the clinic.• Cash burn, trial timelines and dilution remain key concerns.
